BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:The healthcare system plays an integral role in the detection 
 and response of intimate partner violence (IPV)\, a significant public he
 alth problem with far-reaching consequences. The majority of IPV screenin
 g initiatives have historically targeted women of reproductive age\, with
  little known about IPV screening experiences among other patient populat
 ions\, including men. The Veterans Health Administration (VHA) has called
  for an expansion of IPV screening\, providing a unique opportunity for a
  large-scale evaluation of IPV screening and response across patient popu
 lations. This presentation describes mixed-methods findings from a highly
 -partnered evaluation with VHA operations partners\, guided by an integra
 tion of the RE-AIM and CFIR frameworks. Using medical record data from 6\
 ,970\,533 patients (89.8% male) across 135 VHA facilities\, we conducted 
 analyses across RE-AIM components to examine the reach of IPV screening\,
  including differences and disparities between those who were and were no
 t screened across patient characteristics (e.g.\, gender\, age\, race\, e
 thnicity\, sexual orientation\, marital status)\; effectiveness of screen
 ing\; adoption across VHA facilities\, provider types\, and clinical sett
 ings\; and implementation fidelity. Additionally\, data from CFIR-grounde
 d qualitative interviews with providers (n=32) and patients (n=37)\, help
 ed us identify and categorize multilevel factors critical to screening ex
 pansion\, potential barriers and enablers of implementation\, and impact/
 effectiveness of screening on patient outcomes. Integrating RE-AIM and CF
 IR allowed for an in-depth and rich evaluation of the screening and respo
 nse expansion. Findings yield clinical\, policy\, and research implicatio
 ns\, including recommendations for screening implementation initiatives a
 nd/or adaptations\, optimization of strategies for screening implementati
 on across patient populations\, and underscoring the value of integrating
  D&I frameworks for conducting rigorous evaluations.\n\nSpeaker:\nGalina 
 Portnoy\n\nAdmission:\nFree\n\nFood:\nLunch: Boxed lunch will be provided
  with vegan and vegetarian options available\n\nDetails URL:\nhttps://med
 icine.yale.edu/event/cmips-seminar-galina-portnoy-copy/\n
DTEND;TZID=America/New_York:20251030T130000
DTSTAMP:20260422T175652Z
DTSTART;TZID=America/New_York:20251030T120000
LOCATION:URL: https://yale.zoom.us/j/99239993252
SEQUENCE:0
STATUS:Confirmed
SUMMARY:CMIPS Seminar: "Mixed Methods Evaluation of a National Intimate Pa
 rtner Violence Screening Expansion Implementation: Integrating RE-AIM and
  CFIR Frameworks"
UID:5dfb656c-4b16-4f3c-afe0-4ebcf6e347d2
END:VEVENT
END:VCALENDAR